Fosomax

Description

In 2007, Option consommateurs joined the class action against Merck Frosst Canada, the manufacturer of Fosamax. The organization believes that the manufacturer failed to adequately inform consumers and healthcare professionals about the risks associated with the use of this drug, and continued to sell it despite these risks.

Our members

The purpose of the class action was to compensate all Quebec consumers and their loved ones who suffered damages as a result of taking this drug.

Where we are

On July 4, 2011, the motion for authorization to exercise this recourse was dismissed by the Quebec Superior Court. We appealed this decision. In January 2013, the Court of Appeal refused to authorize this recourse.